BioSante Pharmaceuticals Receives NASDAQ Delisting Determination Letter – DailyFinance

BioSante Pharmaceuticals Receives NASDAQ Delisting Determination Letter DailyFinance BAUDETTE, Minn.–(BUSINESS WIRE)– BioSante Pharmaceuticals, Inc. (NAS: BPAX) announced today that on June 20, 2013, it received a letter from NASDAQ informing BioSante that, since the merger with ANIP Acquisition Company d/b/a ANI … and more »

nasdaq – Google News